Announcements

Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth

January 5, 2023

Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses ...

– Gustavo Mahler hired as the Chief Executive Officer of Ncardia and Cellistic, and will join ...

Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction

September 20, 2022

Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing ...

Quell Therapeutics and Cellistic™ enter a strategic collaboration to develop an iPSC-derived allogeneic T-regulatory (Treg) cell therapy platform

April 27, 2022

Quell Therapeutics and Cellistic™ enter a strategic collaboration to ...

– Collaboration combines Quell’s pioneering autologous multi-modular Treg cell therapy ...

Ncardia launches Cellistic™ — purpose-built to make large-scale allogeneic cell therapy production a reality today

April 18, 2022

Ncardia launches Cellistic™ — purpose-built to make large-scale allogeneic ...

Ncardia launches CellisticTM, the only iPSC-based cell therapy process development & ...

← 1 2 3